EP Patent

EP1241110A1 — Dispensing unit for oxygen-sensitive drugs

Assigned to Pfizer Products Inc · Expires 2002-09-18 · 24y expired

What this patent protects

A means for dispensing a single unit dose of an oxygen-sensitive drug without exposing the remaining unit dosages to oxygen is described herein. Each unit dose is individually encapsulated in the pharmaceutical packaging construction such that when one unit dose is dispensed the …

USPTO Abstract

A means for dispensing a single unit dose of an oxygen-sensitive drug without exposing the remaining unit dosages to oxygen is described herein. Each unit dose is individually encapsulated in the pharmaceutical packaging construction such that when one unit dose is dispensed the other unit doses remain encapsulated. An oxygen-absorber is also incorporated into the construction such that the oxygen absorber has sufficient contact with the air surrounding the oxygen-sensitive drug to remove at least a portion of the oxygen in the air to reduce or eliminate undesirable oxidative degradation of the drug in its encapsulated environment.

Drugs covered by this patent

Patent Metadata

Patent number
EP1241110A1
Jurisdiction
EP
Classification
—
Expires
2002-09-18
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Products Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.